Ozempic Weight Loss
Ozempic (semaglutide) is a medication used to treat type 2 diabetes. One of its potential side effects is weight loss. In clinical trials, patients taking Ozempic for 26 weeks lost an average of 4.4 to 6.4% of their body weight.
The weight loss is attributed to Ozempic. It works by simulating the actions of GLP-1, a hormone that manages appetite and food intake.
Ozempic can reduce appetite and increase feelings of fullness. It can also slow down the digestion of food. This can lead to reduced calorie intake and weight loss.
Ozempic is approved in the UK for weight management. It is approved for adults who are either obese or overweight with at least one weight-related condition. Examples of weight-related conditions include high blood pressure and high cholesterol.
In the UK, the eligibility criteria for Ozempic weight loss treatment include:
- A body mass index (BMI) of 30 or higher, or
- A person’s BMI should be 27 or higher for them to be diagnosed with a weight-related condition.
- These conditions include high blood pressure, high cholesterol, and type 2 diabetes.
It is important to note that eligibility for Ozempic treatment is determined by a healthcare professional. This determination is based on an individual’s medical history, current medications, and other factors. Are you interested in Ozempic weight loss treatment? Talk to your doctor to determine whether it is a suitable and safe option.